Davide Bassani

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 15

Top Topics

Helicobacter Pylori

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Teresa Gianferrara, Matteo Pavan, Davide Bassani, Fabrizio Vincenzi, Silvia Pasquini, Giovanni Bolcato, Katia Varani, Giampiero Spalluto, Stephanie Federico, Stefano Moro
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors. ChemMedChem (2023)
Davide Bassani, Alessandro Brigo, Andrea Andrews-Morger
Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon. Chemical research in toxicology (2023)
Andrea Spinaci, Michela Buccioni, Daniela Catarzi, Chang Cui, Vittoria Colotta, Diego Dal Ben, Eleonora Cescon, Beatrice Francucci, Ilenia Grieco, Catia Lambertucci, Gabriella Marucci, Davide Bassani, Matteo Pavan, Flavia Varano, Stephanie Federico, Giampiero Spalluto, Stefano Moro, Rosaria Volpini
"Dual Anta-Inhibitors" of the A 2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Davide Bassani, Stefano Moro
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies. Molecules (Basel, Switzerland) 28 (9) (2023)
Davide Bassani, Stefano Moro
Correction: Bassani, D.; Moro, S. Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies. Molecules 2023, 28 , 3906. Molecules (Basel, Switzerland) 28 (13) (2023)
Davide Bassani, Stefano Moro
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies. Molecules (Basel, Switzerland) 28 (9) (2023)
Maria Chiara Scaini, Luisa Piccin, Davide Bassani, Antonio Scapinello, Stefania Pellegrini, Cristina Poggiana, Cristina Catoni, Debora Tonello, Jacopo Pigozzo, Luigi Dall'Olmo, Antonio Rosato, Stefano Moro, Vanna Chiarion Sileni, Chiara Menin
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants. International journal of molecular sciences 24 (15) (2023)
Daniela Carbone, Michele De Franco, Camilla Pecoraro, Davide Bassani, Matteo Pavan, Stella Cascioferro, Barbara Parrino, Girolamo Cirrincione, Abdolmajid Fata, Stefania Sut, Stefano Moro, Valentina Gandin, Patrizia Diana
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma. Marine drugs 21 (5) (2023)
Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Giovanni Bolcato, Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism? Biomedicines 10 (2) (2022)
Davide Bassani, Matteo Pavan, Mattia Sturlese, Stefano Moro
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists? Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Davide Bassani, Matteo Pavan, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese, Stefano Moro
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? International journal of molecular sciences 23 (9) (2022)
Davide Bassani, Matteo Pavan, Giovanni Bolcato, Mattia Sturlese, Stefano Moro
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M pro . Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, André Volland, Claudia Ascher, Alexander Kurt Hermann Weiss, David Bante, Reuben Stewart Harris, Stefano Moro, Bernhard Rupp, Luis Martinez-Sobrido, Dorothee von Laer
SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Science translational medicine (2022)
Giovanni Bolcato, Eleonora Cescon, Matteo Pavan, Maicol Bissaro, Davide Bassani, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese, Stefano Moro
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ. International journal of molecular sciences 22 (18) (2021)